Company Overview of Applied Immune Technologies Ltd.
Applied Immune Technologies Ltd. engages in the development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications in pathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Gutwirth Industrial Park
Founded in 2006
972 4 8122216
972 4 8122294
Key Executives for Applied Immune Technologies Ltd.
Similar Private Companies By Industry
|Adante Ltd.||Middle East/Africa|
|Quinova Rx Ltd.||Middle East/Africa|
|Immunovative Therapies Ltd.||Middle East/Africa|
|Bio-Rad Haifa Ltd.||Middle East/Africa|
|Rakuto Bio Technologies Ltd.||Middle East/Africa|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Billerica, MA | Mergis Group, A Division of SpherionPosted: Dec 10
- Summit, NJ | DiversantPosted: Jul 03
- Fort Lauderdale, FL | Broward HealthPosted: Dec 16
- Brown Deer, WI | Kelly Scientific ResourcesPosted: Dec 13
Sponsored Financial Commentaries
To contact Applied Immune Technologies Ltd., please visit www.tcrl.co.il. Company data is provided by Capital IQ. Please use this form to report any data issues.